Provided by Tiger Trade Technology Pte. Ltd.

SH PHARMA

11.110
+0.1000.91%
Volume:983.40K
Turnover:10.90M
Market Cap:41.20B
PE:6.12
High:11.190
Open:11.190
Low:10.990
Close:11.010
52wk High:12.170
52wk Low:10.474
Shares:3.71B
HK Float Shares:919.07M
Volume Ratio:0.53
T/O Rate:0.11%
Dividend:0.53
Dividend Rate:4.78%
EPS(LYR):1.816
ROE:6.96%
ROA:2.34%
PB:0.45
PE(LYR):6.12
PS:0.12

Loading ...

AH Share Premium and Deviation Rankings as of June 24th Close

Stock News
·
Jun 24

AH Share Premium and Deviation Rankings as of June 18th

Stock News
·
Jun 18

Shanghai Pharma Announces Election of Zhao Yong as Employee Representative Director for Ninth Board Term

Stock News
·
Jun 17

SH PHARMA elects Zhao Yong as Employee-Representative Director for Ninth Board Term

Bulletin Express
·
Jun 17

Shanghai Pharmaceuticals Gets Nod for Manufacturing of Roxadustat Capsules

MT Newswires Live
·
Jun 15

Major Shareholder Increases Stake in Shanghai Pharma by 38.6 Million H Shares

Deep News
·
Jun 14

Major Shareholder Increases Stake in SH Pharma

Stock News
·
Jun 12

SH Pharma Sets 25 June 2026 for AGM; H-Share Holders Face 15 June Reply Deadline

Bulletin Express
·
Jun 03

SH PHARMA Schedules 25 June 2026 AGM to Review 2025 Performance, Profit Distribution and New Debt Mandate

Bulletin Express
·
Jun 03

SH PHARMA Proposes Final Dividend of RMB 3.5 per 10 Shares

Stock News
·
Jun 03

SH PHARMA 2025 Results: Revenue Reaches RMB 283.58 Billion, Net Profit Jumps 25.74%, 30% Dividend Payout and Up to RMB 15 Billion Debt Issue Planned

Bulletin Express
·
Jun 03

SH PHARMA Reports Stable Share Capital and Full Public-Float Compliance in May 2026

Bulletin Express
·
Jun 01

SH PHARMA Subsidiary Shandong Xinyi Gains Approval as Marketing Authorization Holder for Trazodone Hydrochloride Tablets

Stock News
·
May 28

SH PHARMA's B001 Phase III Trial for NMOSD Concludes Unblinding with Positive Efficacy and Safety Data

Deep News
·
May 27

Shanghai Pharma's Industrial Segment Encompasses a Broad Spectrum of Pharmaceutical and Healthcare Products

Deep News
·
May 27

Shanghai Pharmaceuticals Committed to Business Structure Optimization and Profitability Enhancement

Deep News
·
May 27

SH PHARMA Announces Nominees for Ninth Board of Directors

Stock News
·
May 27

SH PHARMA April 2026 Capital Update: Share Base Steady, 0.68 Million A-Share Options Cancelled

Bulletin Express
·
May 06

Morgan Stanley: Shanghai Pharma's Q1 Results Align with Forecasts, Assigns "In-Line" Rating to A-Shares

Stock News
·
May 06